Neurologist Offers Perspective on Lequembi, Alzheimer’s Drug Newly Approved by FDA
Neurology Associates' Dr. Andrea An discusses the significance of the FDA's new approval for the Alzheimer's drug Lequembi.
top of page
M-F 8 a.m. - 4 p.m. | 480 800 4890 | Insurance Info
Search
Neurology Associates
Mar 13, 20231 min
Long COVID Now Seen as Neurological Condition
For most people, the worst of COVID-19 has passed. But did you know that long COVID continues to impact about 16 million U.S. adults? And...
50 views0 comments
Neurology Associates
Feb 24, 20231 min
Neurologist FAQ #5: Do Neurologists Treat Depression?
Recent statistics indicate that almost one-quarter of U.S. adults felt depressed within the last two weeks. That’s a significant number...
100 views0 comments
Neurology Associates
Feb 24, 20232 min
Neurologist FAQ #4: How Do I Choose the Right Neurologist for Me?
Given the conditions and symptoms outlined in the previous blogs in our series, “FAQs About Neurology and Neurologists,” knowing how to...
109 views0 comments
Kelly Teal
Jan 27, 20232 min
Recent Research Shows Promise for New Parkinson’s-Symptoms Drugs
Researchers at Oregon Health & Science University have made a big discovery regarding Parkinson's.
25 views1 comment
Kelly Teal
Jan 18, 20232 min
Lecanemab Has FDA Approval, But Alzheimer’s Patients Should Proceed With Caution
Neurology Associates Neuroscience Center looks at the side effects of lecanemab, the newly FDA-approved drug for Alzheimer's.
14 views0 comments
Kelly Teal
Dec 21, 20224 min
Meet the Neurology Experts We Added in 2022
Neurology Associates brought on six new experts -- two neurologists, two physician assistants, and two nurse practitioners -- in 2022.
66 views
bottom of page